IFRX logo

IFRX
InflaRx N.V.

10,472
Mkt Cap
$55.81M
Volume
75,173.00
52W High
$2.09
52W Low
$0.7113
PE Ratio
-0.79
IFRX Fundamentals
Price
$0.8601
Prev Close
$0.8313
Open
$0.8349
50D MA
$1.01
Beta
1.04
Avg. Volume
624,400.90
EPS (Annual)
-$0.8457
P/B
1.06
Rev/Employee
$2,423.41
$91.65
Loading...
Loading...
News
all
press releases
InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Analysts
InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. One research...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the stock, MarketBeat reports. One...
MarketBeat·1mo ago
News Placeholder
InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder
InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.read more...
Benzinga·1mo ago
News Placeholder
Short Interest in InflaRx N.V. (NASDAQ:IFRX) Increases By 26.7%
InflaRx N.V. (NASDAQ:IFRX - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 2,745,086...
MarketBeat·1mo ago
News Placeholder
InflaRx (NASDAQ:IFRX) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $6.00 price target on shares of InflaRx in a research report on Tuesday...
MarketBeat·2mo ago
News Placeholder
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts
InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports...
MarketBeat·2mo ago
News Placeholder
InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, Marketbeat.com reports. One...
MarketBeat·3mo ago
News Placeholder
Is InflaRx NV Gaining or Losing Market Support?
read more...
Benzinga·3mo ago
News Placeholder
FY2026 EPS Estimates for InflaRx Raised by Cantor Fitzgerald
InflaRx N.V. (NASDAQ:IFRX - Free Report) - Investment analysts at Cantor Fitzgerald lifted their FY2026 earnings per share estimates for InflaRx in a report released on Tuesday, November 11th. Cantor...
MarketBeat·3mo ago
News Placeholder
FY2025 EPS Estimates for InflaRx Reduced by HC Wainwright
InflaRx N.V. (NASDAQ:IFRX - Free Report) - Stock analysts at HC Wainwright decreased their FY2025 earnings estimates for InflaRx in a report released on Monday, November 10th. HC Wainwright analyst...
MarketBeat·3mo ago
<
1
2
...
>

Latest IFRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.